$24.43
-0.35-1.41%
At close: -
As of Feb 28, 2025
The 2023 ETF Series Trust II GMO US Value ETF (ARCA: GMOV)
Ticker | Name | Share % | |
---|---|---|---|
JNJ | Johnson & Johnson, Inc. | 3.80% | |
XOM | Exxon Mobil Corp | 3.60% | |
JPM | Jpmorgan Chase & Co Common Stock Usd 1 | 3.30% | |
CVX | Chevron Corp | 3.00% | |
CSCO | Cisco Systems Inc | 2.90% | |
VZ | Verizon Communications Inc Vz | 2.80% | |
CMCSA | Comcast Corporation (Class A) | 2.50% | |
PFE | Pfizer, Inc., Common Stock | 2.40% | |
CI | The Cigna Corp. | 2.40% | |
MRK | Merck & Co. Inc | 2.40% |
The GMOV ETF is currently trading at $24.43, which represents a -1.41% change. Over the past 52 weeks, the ETF has traded as high as $26.28 and as low as $23.85.
The expense ratio of GMOV is 0.5%. This represents the annual fee that all funds or ETFs charge their shareholders.
Assets Under Management (AUM) data for GMOV is currently not available.
GMOV follows a Large Cap Value investment style.
The top holdings of GMOV include: JNJ (3.8%), XOM (3.6%), JPM (3.3%), CVX (3%), CSCO (2.9%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for GMOV is currently not available.